{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:31:40Z","timestamp":1787959900025,"version":"build-2784847793"},"reference-count":22,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,12,15]]},"DOI":"10.18632\/aging.104133","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T05:54:55Z","timestamp":1605938095000},"page":"24219-24227","source":"Crossref","is-referenced-by-count":18,"title":["Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study"],"prefix":"10.18632","volume":"12","author":[{"given":"Jung-Chi","family":"Hsu","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Camillian Saint Mary\u2019s Hospital Luodong, Yilan, Taiwan"},{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Camillian Saint Mary\u2019s Hospital Luodong, Yilan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Electrophysiology, Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.4022\/jafib.1556","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: diagnosis and considerations for management.","volume":"1","author":"Aydin","year":"2018","journal-title":"J Atr Fibrillation"},{"key":"2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.","volume":"3","author":"Spirito","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).","volume":"1","author":"Elliott","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2018.08.038","article-title":"Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: a nationwide population-based study.","volume":"27","author":"Oh","year":"2018","journal-title":"Int J Cardiol"},{"key":"5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.hrthm.2018.11.029","article-title":"Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation.","volume":"1","author":"Yamagishi","year":"2019","journal-title":"Heart Rhythm"},{"key":"6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0038-1676818","article-title":"Hypertrophic cardiomyopathy in patients with atrial fibrillation: prevalence and associated stroke risks in a nationwide cohort study.","volume":"11","author":"Joung","year":"2019","journal-title":"Thromb Haemost"},{"key":"7","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/j.hrthm.2019.04.001","article-title":"Reply to the editor- patients with atrial fibrillation with hypertrophic cardiomyopathy: do we need new stroke risk stratification?","volume":"1","author":"Hayashi","year":"2019","journal-title":"Heart Rhythm"},{"key":"8","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC).","volume":"3","author":"Nihoyannopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/0002-9149(83)90317-x","article-title":"Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.","volume":"5","author":"Rosing","year":"1983","journal-title":"Am J Cardiol"},{"key":"10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/0002-9149(94)90151-1","article-title":"Heterogeneity of left ventricular filling dynamics in hypertrophic cardiomyopathy.","volume":"7","author":"Chiariello","year":"1994","journal-title":"Am J Cardiol"},{"key":"11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.echo.2004.02.010","article-title":"Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.","volume":"1","author":"Katayama","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000354953","article-title":"Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.","volume":"12","author":"Song","year":"2013","journal-title":"Cardiology"},{"key":"13","doi-asserted-by":"publisher","first-page":"11347","DOI":"10.18632\/aging.102532","article-title":"Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study.","volume":"1","author":"Wu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jacc.2010.09.049","article-title":"Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation.","volume":"5","author":"Marrouche","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jacep.2018.10.016","article-title":"Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.","volume":"5","author":"Nazarian","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/STROKEAHA.115.012130","article-title":"Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation.","volume":"4","author":"Hagiwara","year":"2016","journal-title":"Stroke"},{"key":"17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000338156","article-title":"Holter monitoring and long-term prognosis in hypertrophic cardiomyopathy.","volume":"12","author":"Sugihara","year":"2012","journal-title":"Cardiology"},{"key":"18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.amjcard.2016.08.092","article-title":"Incidence of device-detected atrial fibrillation and long-term outcomes in patients with hypertrophic cardiomyopathy.","volume":"11","author":"Schinkel","year":"2017","journal-title":"Am J Cardiol"},{"key":"19","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.amjcard.2017.02.040","article-title":"Occurrence and natural history of clinically silent episodes of atrial fibrillation in hypertrophic cardiomyopathy.","volume":"11","author":"Maron","year":"2017","journal-title":"Am J Cardiol"},{"key":"20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00392-015-0876-6","article-title":"Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?","volume":"10","author":"Thomas","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"21","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s00380-015-0718-5","article-title":"Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of \u22641 and without anticoagulant therapy.","volume":"3","author":"Li","year":"2016","journal-title":"Heart Vessels"},{"key":"22","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.jacc.2018.07.098","article-title":"Stroke risk stratification for atrial fibrillation patients with hypertrophic cardiomyopathy.","volume":"7","author":"Lip","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.104133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T15:49:33Z","timestamp":1617724173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.104133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":22,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,12,15]]}},"alternative-id":["104133","33226371"],"URL":"https:\/\/doi.org\/10.18632\/aging.104133","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]}}}